Concepedia

N Aiyar

NA

Statistics

Publications

9

Citations

442

H-Index

9

Active since

1987

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

N Aiyar is an author at GlaxoSmithKline (United States) specializing in vascular biology, drug discovery, and neuropharmacology.

Top concepts

MedicinePhysiologyBiochemistryPharmacologyDrug DiscoveryCell PhysiologyPharmacotherapyVascular BiologyNeuropharmacologySignal Transduction

Publications per year

1987–2010

9

Publications

9

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

David G. Johns, David J. Behm, Deborah J. Walker et al. · British Journal of Pharmacology · 2007 · 241 citations · Full text

Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line.

N Aiyar, P Nambi, M Whitman et al. · Molecular Pharmacology · 1987 · 49 citations

Characterization of renal angiotensin II receptors using subtype selective antagonists.

Richard M. Edwards, E J Stack, Edwin F. Weidley et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 43 citations

GSK1562590, a slowly dissociating urotensin‐II receptor antagonist, exhibits prolonged pharmacodynamic activity <i>ex vivo</i>

DJ Behm, N Aiyar, AR Olzinski et al. · British Journal of Pharmacology · 2010 · 26 citations · Full text

Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.

Richard M. Edwards, N Aiyar, Eliot H. Ohlstein et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 24 citations

1–5 of 9